ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Deals this week: AstraZeneca, Yuhan, Bristol-Myers
November 10, 2018Covis Pharma currently markets the drugs in the US. The divestment will enable AstraZeneca to focus on the development of new and innovative drugs to fulfil the unmet needs of patients. -
NICE rejects Roche’s Tecentriq for pre-treated urothelial cancer
December 25, 2017Cost regulators for NHS treatments in England and Wales have turned down Roche’s Tecentriq for patients who have already received prior treatment for metastatic urothelial cancer. -
Priority review for Merck, Pfizer’s avelumab in urothelial cancer
March 02, 2017US regulators have agreed to undertake a priority review Merck and Pfizer's avelumab as ...
Pharma Sources Insight January 2025
